Bystolic Trademark Details

Bystolic was registered on Tuesday, April 21, 2009 and is currently owned by Forest Laboratories, Inc. under the registration number 3609793 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 10 years ago on Tuesday, May 20, 2014, according to the United State Patent & Trademark Office
Word Mark Bystolic
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged

Current Owner

Forest Laboratories, Inc. of New York, NY

View all trademarks for Forest Laboratories, Inc.
Other Trademarks for Forest Laboratories, Inc.
Serial Number 77363854
Registration Number 3609793
Status Date Tuesday, May 20, 2014
Filing Date Tuesday, May 20, 2014
Registration Date Tuesday, April 21, 2009
Attorney Christopher Serbagi

Correspondent

Christopher Serbagi
THE SERBAGI LAW FIRM
488 MADISON AVE STE 1120
NEW YORK NY 10022-5719

Case File Statements

Amendment to a Registration/Renewal Certificate In the statement, column 1, line 6, "isolated" is deleted and lines 7 thru 23, are deleted and in the statement, column 2, lines, 1, 2, 3, 4 and 5, are deleted.
Indication of Colors The color(s) blue and orange is/are claimed as a feature of the mark.
Description of Mark The mark consists of the word "BYSTOLIC" in the color blue with two arrows forming a circle, one of the arrows is in the color blue and the other arrow is in the color orange.
Goods & Services Pharmaceutical preparations for the treatment of Hypertension [, Isolated Systolic Hypertension, Essential Hypertension, Hypertension with Renal Disease, Primary Pulmonary Hypertension, Hypertension Encephalopathy, Congestive Heart Failure, Diastolic Heart Failure, Peripheral Vascular Disease, Ventricular Dysfunction following Myocardial Infarction, Definite or Suspected Acute Myocardial Infarction, Angina Pectoris, Chest Pain, Neuropathy in Type II Diabetics, Treatment of Endothelial Dysfunction, Coronary Artery Disease, Chronic Ischaemic Disease, Artrial Fibrillation and Flutter, Coronary Atherosclosis, Atheroscherosis Renal Arteries, Diabetes with Renal Manifestations, Mitral Valve Disorders, Aortic Valve Disorders, Tachycardia, Cardiac Dysrhythmias, Primary Cardiomyopathy, Metabolic Syndrome, Pulmonary Valve Disorder, Migraine, and Prevention of Migraine ]

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, January 8, 2008
First Use Anywhere Monday, January 7, 2008
First Use In Commerce Monday, January 7, 2008
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.